{"Q": 1, "answer": "no", "rationale": "The segment describes testing plans, but does not use an intensifier or comparative modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_14472", "batch_size": 200, "batch_pos": 82, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The segment describes vaccine testing timelines factually, without high-potency language.", "method": "llm_batch", "batch_id": "batch_2_8168", "batch_size": 200, "batch_pos": 22, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "This describes future action/expectation ('would begin', 'expected'), not realised impact.", "method": "llm_batch", "batch_id": "batch_3_15012", "batch_size": 200, "batch_pos": 168, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "The segment contains no question.", "method": "llm_batch", "batch_id": "batch_4_16792", "batch_size": 200, "batch_pos": 152, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "The segment reports testing timeline but contains no explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_17848", "batch_size": 200, "batch_pos": 148, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "Segment does not contain a minimiser used in conjunction with a scale contrast.", "method": "llm_batch", "batch_id": "batch_6_15492", "batch_size": 200, "batch_pos": 103, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_15604", "batch_size": 200, "batch_pos": 88, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 8, "answer": "yes", "rationale": "The segment describes 'late-stage testing would begin', a capability/preparedness.", "method": "llm_batch", "batch_id": "batch_8_16668", "batch_size": 200, "batch_pos": 120, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
